Pharmora
Pharmora Solutions Ltd, commonly referred to as Pharmora, is a leading player in the pharmaceutical and healthcare industry, headquartered in Great Britain. Founded in 2015, the company has rapidly established itself as a key provider of innovative solutions across Europe and beyond, focusing on clinical trial management, regulatory affairs, and market access strategies. Pharmora's core offerings include comprehensive consulting services and advanced technology platforms designed to streamline drug development processes. What sets Pharmora apart is its commitment to delivering tailored solutions that enhance efficiency and compliance for clients in the life sciences sector. With a strong market position, Pharmora has achieved notable milestones, including successful partnerships with major pharmaceutical companies, solidifying its reputation as a trusted industry expert.
DitchCarbon Score
How does Pharmora's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Pharmora's score of 6 is higher than 59% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmora's reported carbon emissions
Pharmora Ltd, headquartered in the United Kingdom, currently does not report any specific carbon emissions data. However, the company has made significant climate commitments aimed at reducing its greenhouse gas emissions. Pharmora has set a target to maintain zero Scope 1 emissions through 2030, demonstrating a commitment to eliminating direct emissions from its operations. Additionally, the company aims to reduce its absolute Scope 2 greenhouse gas emissions by 42% by 2030, using 2022 as the baseline year. Furthermore, Pharmora is committed to measuring and reducing its Scope 3 emissions, which encompass indirect emissions from its value chain. These targets align with the Science Based Targets initiative (SBTi) and are consistent with the reductions necessary to limit global warming to 1.5°C.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Pharmora is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
